Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Solid Biosciences Inc. publishes a filing, an earnings call transcript or a press release.

Get SLDB alerts

About Alexander (Bo) Cumbo

Alexander (Bo) Cumbo is recorded as CEO and Board Member at Solid Biosciences Inc. (SLDB) since December 2, 2022. The newest filing on record that lists Alexander (Bo) Cumbo as CEO and Board Member at Solid Biosciences Inc. (SLDB) is dated April 23, 2026. Solid Biosciences Inc. reported in an 8-K filed June 13, 2025 a re-election or new board role (Class I director) for Alexander (Bo) Cumbo, on the board since at least 2022, effective June 12, 2025. Solid Biosciences Inc. reported in an 8-K filed December 5, 2022 that Alexander (Bo) Cumbo was appointed President and Chief Executive Officer, effective December 2, 2022. Solid Biosciences Inc. reported in an 8-K filed September 30, 2022 that Alexander (Bo) Cumbo was appointed board of directors. Equibles holds 4 filed executive changes naming Alexander (Bo) Cumbo; each is listed under recent activity with its source filing. The proxy statement of Solid Biosciences Inc. reports total compensation of $5,223,442 for Alexander (Bo) Cumbo in fiscal 2025, including a base salary of $650,988. Disclosed compensation is on record for 4 fiscal years. Solid Biosciences Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Solid Biosciences Inc. includes Bo Cumbo (CEO and Board Member), Ian F. Smith (Chairman), Kevin Tan (CFO and Chief Accounting Officer) and 7 others.

“The Company’s stockholders elected Alexander Cumbo and Sukumar Nagendran as Class I directors to serve until the 2028 Annual Meeting of Stockholders, each director to hold office until his successor has been duly appointed and qualified.”
Solid Biosciences Inc. Form 8-K, filed June 13, 2025 · Read the filing
“On November 30, 2022, the Board appointed Alexander (Bo) Cumbo as the Company's President and Chief Executive Officer and elected Mr. Cumbo as a member of the Board, in each case, subject to and contingent and effective upon the closing of the Acquisition (the "Effective Date").”
Solid Biosciences Inc. Form 8-K, filed December 5, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Solid Biosciences Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Solid Biosciences Inc. (SLDB) $650,988 $5,223,442
2024 Solid Biosciences Inc. (SLDB) $608,400 $4,869,909
2023 Solid Biosciences Inc. (SLDB) $585,000 $918,630
2022 Solid Biosciences Inc. (SLDB) $45,519 $2,200,212

Recent activity